News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 73–108
- Matches
- 5294
- Sources here
- 23
- Companies here
- 31
Active search
5294 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Manulife Asia wins Best Overall AI Adoption: Life/Health at 2026 Asia Consumer Insurance Awards
HONG KONG, Aug. 18, 2026 /PRNewswire/ -- Manulife Asia has been named winner of the Best Overall AI Adoption: Life/Health award at the 2026 Asia Consumer Insurance Awards, organized by (Re)Insurance Asia. The award recognizes life and health insurers that have demonstrated broad-based adoption …
Sharemaestro market context Trend signal active 52 weeks +46.9% · Next-week setup positive 57.9%Flputnam Investment Management Co. Acquires New Holdings in AirSculpt Technologies, Inc. $AIRS
Flputnam Investment Management Co. has acquired a new stake in AirSculpt Technologies, Inc. (NASDAQ:AIRS), purchasing 691,989 shares valued at approximately $3.1 million. This acquisition gives Flputnam Investment Management a 0.98% stake in the company, which is 91.54% owned by institutional investors. AirSculpt Technologies recently …
The Latest Beauty Executive Moves at Ulta Beauty, Kosas and More
Ulta Beauty, The Estée Lauder Cos., Kosas, and other beauty companies have announced significant executive appointments. Kelly Garcia will join Ulta Beauty as chief technology officer, Madeleine Boyd is the new senior vice president of global brand communications at The Estée Lauder Cos., and …
Latham Advises Frazier Life Sciences on Private Placement Financing With Fulcrum Slate Merger
Latham & Watkins LLP advised Frazier Life Sciences on an oversubscribed US$245 million private placement financing. This financing supports the merger between Fulcrum Therapeutics, Inc. (Nasdaq: FULC) and Slate Medicines, Inc., an all-stock transaction. The combined company will focus on advancing Slate’s pipeline, including …
Form 8K Fulcrum Therapeutics Inc For: 17 August By Investing.com
This article reports that Fulcrum Therapeutics Inc. filed a Form 8K on August 17. The filing is brief and does not provide further details within the article text. The content also includes market data and related news headlines.
Cingulate CEO Dr. Shane J. Schaffer: Why a Child's ADHD Diagnosis Often Reveals ADHD in a Parent
Dr. Shane J. Schaffer, CEO of Cingulate Inc. (NASDAQ: CING), explains how a child's ADHD diagnosis frequently leads to parents recognizing similar symptoms in themselves, highlighting ADHD's strong heritability. He discusses how cultural shifts, improved public understanding, and reduced stigma are contributing to increased …
Datavault AI Inc. Investors Have Until October 5th to Contact Bragar Eagel & Squire, P.C. Seeking Lead Plaintiff Role
Bragar Eagel & Squire, P.C. has filed a class action lawsuit against Datavault AI Inc. (NASDAQ:DVLT) on behalf of investors who purchased securities between September 4, 2024, and October 30, 2025. The lawsuit alleges that Datavault AI made materially false and misleading statements regarding …
Ulta Beauty (ULTA) Sees a More Significant Dip Than Broader Market: Some Facts to Know
In the latest close session, Ulta Beauty (ULTA) was down 3.42% at $493.27. The stock trailed the S&P 500, which registered a daily loss of 0.52%. Elsewhere, the Dow lost 0.51%, while the tech-heavy Nasdaq lost 0.32%. The beauty products retailer's shares have seen …
Sharemaestro market context Price below Trend Line 52 weeks -4.1% · Next-week setup negative 34.1%Lululemon (LULU) Dips More Than Broader Market: What You Should Know
Lululemon (LULU) closed at $115.74 in the latest trading session, marking a -3.19% move from the prior day. The stock's performance was behind the S&P 500's daily loss of 0.52%. At the same time, the Dow lost 0.51%, and the tech-heavy Nasdaq lost 0.32%. …
Sharemaestro market context Price below Trend Line 52 weeks -47.2% · Next-week setup negative 45.0%Insight Molecular Diagnostics (IMDX) Q2 2026 Earnings Call Transcript
Insight Molecular Diagnostics (IMDX) reported its Q2 2026 earnings, detailing a transition from a product development-stage company towards revenue generation as it nears FDA marketing authorization for GraftAssureDx. The company saw net revenue of $239,000, a gross profit of $157,000, and a GAAP net …
Insight Molecular Diagnostics advances heart transplant rejection testing with new DNA-based methods.
Insight Molecular Diagnostics is expanding its blood-based DNA test, GraftAssureDx, from kidney transplant patients to heart transplant rejection, seeking FDA approval. This development aims to improve monitoring and outcomes for heart transplant recipients by simplifying the detection of rejection. Expert insights suggest the new …
lululemon athletica inc. stock outperforms competitors despite losses on the day
Shares of lululemon athletica inc. (LULU) declined by 3.19% to $115.74, marking its sixth consecutive day of losses, despite an overall poor trading session for the stock market. Both the S&P 500 Index and Dow Jones Industrial Average also experienced declines. The article highlights …
Scott Bizily plans new 4D Molecular (NASDAQ: FDMT) sale after 10b5-1 stock trades
Scott Bizily plans to sell 6,540 shares of 4D Molecular Therapeutics (NASDAQ: FDMT) on August 17, 2026, following the exercise of stock options. This transaction, processed through Morgan Stanley Smith Barney LLC, has an associated value of $79,722.60. The filing also details three previous …
4D Molecular Therapeutics (NASDAQ: FDMT) legal chief sells 3,270 shares
Scott Bizily, Chief Legal Officer of 4D Molecular Therapeutics (FDMT), sold 3,270 shares of common stock after exercising options. The transactions occurred on August 13 and August 17, 2026, with sales at $12.00 and $12.20 per share, respectively, and were executed under a Rule …
Gulf Resources : Annual Report for Fiscal Year Ending December 31, 2025 (Form 10-K)
Gulf Resources reported a reduced net loss of $43,920,231 for fiscal year 2025, a significant improvement from $59,900,372 in 2024, driven by increased sales in its bromine and crude salt segments. The company's net revenue soared by 232% to $25,418,335 in 2025, primarily due …
Kulicke and Soffa Industries, Inc. Appoints Dr. Raj Talluri as President and CEO
SINGAPORE, Aug. 17, 2026 /PRNewswire/ -- Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC) ("Kulicke & Soffa", "K&S", "we" or the "Company") today announced that it has named Dr. Raj Talluri as President and Chief Executive Officer ("CEO") effective September 1, 2026. He was also …
Huron Consulting Group (HURN) Could Be 18% Undervalued After Raised EPS Guidance
Huron Consulting Group (HURN) has seen renewed interest after its latest earnings report, with revenue up 15.4% year-on-year and raised full-year EPS guidance. The stock's recent 32.29% 30-day return suggests growing momentum, and a common market narrative indicates it could still be 17.6% undervalued, …
Manulife Financial Corp. stock falls Monday, underperforms market
Manulife Financial Corp. (MFC) shares dropped 0.53% on Monday, underperforming the broader Canadian market which saw the S&P/TSX Composite Index fall 0.17%. The stock closed at C$61.40, which is 3.4% below its 52-week high of C$63.58 reached on August 6th.
Ancora Eyes H.B. Fuller’s Building Adhesives Segment
Ancora Holding Group has publicly proposed acquiring H.B. Fuller’s Building Adhesives Solutions (BAS) segment for $1.1 to $1.2 billion in cash. Ancora believes this sale would allow H.B. Fuller to exit a lower-margin segment in a fragmented market. H.B. Fuller acknowledged the proposal and …
Fulcrum Therapeutics (NASDAQ: FULC) backs $245M migraine venture with Slate
Fulcrum Therapeutics and Slate Medicines announced an all-stock merger, forming a new entity named Slate Medicines, Inc. that will trade on Nasdaq as "SLTE." The combined company will focus on Slate's pipeline, particularly SLTE-1009 for migraine prevention, supported by a $245 million private placement …
Star Bulk (NASDAQ: SBLK) insider targets $322.8K share sale
Star Bulk Carriers insider Charis Plakantonaki has filed a Form 144 notice to sell 10,825 common shares of SBLK, valued at $322,802.58. These shares were issued under a Company Equity Incentive Award from May 20, 2025. The filing also notes a previous sale of …
Star Bulk (NASDAQ: SBLK) affiliate plans sale after $208K 10b5-1 trade
An affiliate of Star Bulk Carriers Corp. (SBLK) has filed a Form 144 notice to sell 6,821 shares of common stock, valued at approximately $198,150.05, through Morgan Stanley Smith Barney LLC Executive Financial Services starting August 17, 2026. These shares are linked to an …
Lululemon brings ‘Like New’ resale program to Canada
Lululemon has expanded its "Like New" resale program to Canada, allowing customers to buy and sell used branded products. The athletic apparel retailer partnered with branded resale platform Archive for the Canadian launch, following a successful pilot in the U.S. in 2021 and a …
Insider Selling: Manulife Financial (TSE:MFC) Insider Sells 6,843 Shares of Stock
Manulife Financial insider Patrick David Graham sold 6,843 shares of the company's stock on August 14th at an average price of C$62.06, totaling approximately C$424,677. The company's shares closed at C$61.39, and it recently declared a quarterly dividend of C$0.485, representing a 3.2% annualized …
Law Offices of Howard G. Smith Encourages Datavault AI, Inc. (DVLT) Shareholders To Inquire About Securities Fraud Class Action
The Law Offices of Howard G. Smith announced a class action lawsuit filed on behalf of Datavault AI, Inc. (DVLT) investors who purchased stock between September 4, 2024, and October 30, 2025. The lawsuit alleges that Datavault AI made materially false and misleading statements, …
Ulta Beauty Inc. stock underperforms Monday when compared to competitors
Ulta Beauty Inc. (ULTA) stock fell by 3.41% on Monday, closing at $493.33, underperforming the broader market as the S&P 500 and Dow Jones Industrial Average also saw declines. This marked the sixth consecutive day of losses for Ulta Beauty's stock.
PulteGroup Inc. stock outperforms competitors despite losses on the day
PulteGroup Inc. (PHM) shares fell 1.30% to $128.49 on Monday, experiencing its second consecutive day of losses. Despite this, the stock outperformed the broader market, as the S&P 500 Index (SPX) dropped 0.52% and the Dow Jones Industrial Average (DJIA) fell 0.51% on the …